Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yinling Yun"'
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 450-461 (2021)
Rheumatoid arthritis is a chronic systemic disease characterised by an unknown aetiology of inflammatory synovitis. A large number of studies have shown that synoviocytes show tumour-like dysplasia in the pathological process of RA, and the changes i
Externí odkaz:
https://doaj.org/article/ecca5ccddb144ce9a5649bfc621c2e1a
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1345-1355 (2021)
Alzheimer's disease (AD) is a type of progressive dementia caused by degeneration of the nervous system. A single target drug usually does not work well. Therefore, multi-target drugs are designed and developed so that one drug can specifically bind
Externí odkaz:
https://doaj.org/article/f12c9775105a4526af0d279d89447961
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 805-814 (2020)
Multi-target drugs can better address the cascade of events involved in oxidative stress and the reduction in cholinergic transmission that occur in Alzheimer’s disease than cholinesterase inhibitors alone. We synthesised a series of 3-arylbenzofur
Externí odkaz:
https://doaj.org/article/970ba2fd2a964aac88222406a9542fb6
Autor:
Yuhang Miao, Canhua Hao, Zhang Qiang, Sun Xiaoya, Xiao-Jing Wang, Yinbo Pan, Yinling Yun, Jie Sun
Publikováno v:
New Journal of Chemistry. 45:17287-17300
Benzylaminocoumarin is a kind of compound with coumarin skeleton and benzylamino side chain structure at positions 3 and 4. Our group has previously explored the AD activity of 3-(4-aminophenyl) coumarin and obtained benzylaminocoumarin by further st
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
article-version (VoR) Version of Record
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1345-1355 (2021)
article-version (VoR) Version of Record
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1345-1355 (2021)
Alzheimer's disease (AD) is a type of progressive dementia caused by degeneration of the nervous system. A single target drug usually does not work well. Therefore, multi-target drugs are designed and developed so that one drug can specifically bind
Publikováno v:
Journal of Saudi Chemical Society, Vol 24, Iss 2, Pp 151-185 (2020)
Palladium is a precious metal, which has been widely used for various organic transformations in the past decades. Currently, the palladium-catalyzed direct activation of the aromatic ring C–H bonds is one of the frontier areas in organic chemistry
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 805-814 (2020)
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry
Multi-target drugs can better address the cascade of events involved in oxidative stress and the reduction in cholinergic transmission that occur in Alzheimer’s disease than cholinesterase inhibitors alone. We synthesised a series of 3-arylbenzofur
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
article-version (VoR) Version of Record
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 450-461 (2021)
article-version (VoR) Version of Record
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 450-461 (2021)
Rheumatoid arthritis is a chronic systemic disease characterised by an unknown aetiology of inflammatory synovitis. A large number of studies have shown that synoviocytes show tumour-like dysplasia in the pathological process of RA, and the changes i
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(4)
Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (A
Autor:
Yun, Yinling1 (AUTHOR), Miao, Yuhang1 (AUTHOR), Sun, Xiaoya1 (AUTHOR), Sun, Jie1 (AUTHOR), Wang, Xiaojing1 (AUTHOR)
Publikováno v:
Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2021, Vol. 36 Issue 1, p1345-1355. 11p.